Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis
Abstract Background The effect and safety of atropine on delaying the progression of myopia has been extensively studied, but its optimal dose is still unclear. Therefore, the purpose of this meta-analysis is to systematically evaluate the safety and effectiveness of atropine in controlling the prog...
Main Authors: | Congling Zhao, Chunyan Cai, Qiang Ding, Hongbin Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-020-01746-w |
Similar Items
-
The Role of Atropine in Preventing Myopia Progression: An Update
by: Alberto Chierigo, et al.
Published: (2022-04-01) -
Safety and efficacy of low-dose topical atropine for slowing down progression of myopia in children and adolescents
by: Ahmed A Alhagaa, et al.
Published: (2021-01-01) -
Efficacy and safety of atropine to control childhood myopia progression
by: Martyna Lewkowicz, et al.
Published: (2022-06-01) -
Atropine in the treatment of childhood myopia
by: Sanitha Sathyan
Published: (2019-01-01) -
The diluted atropine for inhibition of myopia progression in Korean children
by: Ji-Sun Moon, et al.
Published: (2018-10-01)